Nephros Stock Widgets and Gadgets
NEPH Stock | USD 2.14 0.05 2.39% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- NEPH Nephros
- Latest Nephros, Inc.s Profit Outlook
- NEPH 2.14 0.05
- Low 2.1
- High 2.14
- Volume 1.2 K
- Alpha -0.82
- Beta 1.06
- Return On Equity -0.18
- Return On Asset -0.0871
- Profit Margin (0.11) %
- Operating Margin (0.20) %
- Current Valuation 19.67 M
- Shares Outstanding 10.54 M
- Shares Owned By Insiders 11.96 %
- Shares Owned By Institutions 40.28 %
- Number Of Shares Shorted 2.56 K
- Price To Earning (4.51) X
- Price To Book 2.52 X
- Price To Sales 1.48 X
- Revenue 14.24 M
- Gross Profit 4.73 M
- EBITDA (1.38 M)
- Net Income (1.57 M)
- Cash And Equivalents 4.18 M
- Cash Per Share 0.41 X
- Total Debt 1.84 M
- Debt To Equity 0.07 %
- Current Ratio 5.27 X
- Book Value Per Share 0.79 X
- Cash Flow From Operations 827 K
- Short Ratio 0.13 X
- Earnings Per Share (0.15) X
- Target Price 4.75
- Number Of Employees 31
- Beta 1.26
- Market Capitalization 22.14 M
- Total Asset 11.86 M
- Retained Earnings (144.41 M)
- Working Capital 6.29 M
- Current Asset 1.53 M
- Current Liabilities 684 K
- Net Asset 11.86 M
- Accumulation Distribution 23.21
- Daily Balance Of Power 1.25
- Rate Of Daily Change 1.02
- Day Median Price 2.12
- Day Typical Price 2.13
- Price Action Indicator 0.045
- Period Momentum Indicator 0.05
- Relative Strength Index 36.26
Market Snapshot Widget Example
DAX Index Germany | 18,138 1.55 | |
Taiwan Weighted Taiwan | 19,599 0.97 | |
PSI 20 Stock Portugal | 6,593 1.19 | |
CROBEX Croatia | 2,787 0.58 | |
Budapest SE Hungary | 65,939 1.25 | |
IDX 30 Jakarta Indonesia | 470.35 0.61 | |
ISEQ 20 Price Ireland | 1,646 0.39 | |
NYSE Comp USA | 17,793 1.08 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,041 1.46 | |
IPC MEXICO Mexico | 56,634 0.41 | |
KL Technology Malaysia | 63.18 0.78 | |
IBEX 35 Index Spain | 11,075 1.70 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,581 0.75 | |
SPASX Dividend Opportunities Australia | 1,656 0.07 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.23 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,291 0.09 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,164 0.75 | |
Basic Materials Brazil | 5,842 2.07 | |
Swiss Leader Price Switzerland | 1,870 1.24 | |
Fondo Mutuo ETF Chile | 1,420 0.97 | |
Athens General Comp Greece | 1,448 1.93 | |
Stock Exchange Of Thailand | 1,357 0.59 | |
PX Prague Stock Czech Repub | 1,551 0.42 | |
THE PHILIPPINE STOCK Philippines | 6,507 0.97 | |
WIG 30 Poland | 3,078 0.76 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Nephros in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Nephros
Compare Nephros To Peers
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nephros. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.